Patent · US Active

Selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors

US10550097B2 · kind B2 · utility

0Cited by

0References

21Claims

0Family size

Assignee

DSM IP ASSETS B.V. · NL

Inventors

Stéphanie Boudon · Kaiseraugst, CH
Piero Geotti-Bianchini · Basel, CH
Marc Heidl · Weil am Rhein, DE
Eileen Jackson · Kaiseraugst, CH
Alexander Schlifke-Poschalko · Kaiseraugst, CH

Key dates

Filing date	Jul 7, 2016
Grant date	Feb 4, 2020
Priority date	—
Expiry date	Jul 7, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D265/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.